BlackRock’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $323M | Sell |
|
|||||
|
2022
Q2 | $152M | Sell |
|
|||||
|
2022
Q1 | $183M | Sell |
|
|||||
|
2021
Q4 | $157M | Sell |
|
|||||
|
2021
Q3 | $147M | Buy |
|
|||||
|
2021
Q2 | $202M | Buy |
|
|||||
|
2021
Q1 | $171M | Buy |
|
|||||
|
2020
Q4 | $160M | Buy |
|
|||||
|
2020
Q3 | $183M | Sell |
|
|||||
|
2020
Q2 | $227M | Sell |
|
|||||
|
2020
Q1 | $244M | Sell |
|
|||||
|
2019
Q4 | $386M | Sell |
|
|||||
|
2019
Q3 | $241M | Buy |
|
|||||
|
2019
Q2 | $236M | Buy |
|
|||||
|
2019
Q1 | $226M | Buy |
|
|||||
|
2018
Q4 | $173M | Buy |
|
|||||
|
2018
Q3 | $159M | Buy |
|
|||||
|
2018
Q2 | $187M | Buy |
|
|||||
|
2018
Q1 | $157M | Sell |
|
|||||
|
2017
Q4 | $131M | Sell |
|
|||||
|
2017
Q3 | $110M | Buy |
|
|||||
|
2017
Q2 | $93.1M | Buy |
|
|||||
|
2017
Q1 | $96.5M | Buy |
|
|||||
|
2016
Q4 | $792K | Buy |
|
|||||
|
2016
Q3 | $1.15M | Buy |
|
|||||
|
2016
Q2 | $812K | Buy |
|
|||||
|
2016
Q1 | $6K | Sell |
|
|||||
|
2015
Q4 | $29K | Sell |
|
|||||
|
2015
Q3 | $1.34M | Buy |
|